Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2024; 14(1): 292-303


Ameliorative effects of berberine and selenium against paracetamol-induced hepatic toxicity in rats

Gamal Shams,Somia Abd Allah,Raghda Ezzat,Mahmoud A. Said.




Abstract
Cited by 0 Articles

Background:
Paracetamol (PCM) overdosing induces hepatotoxicity, which can result in death if the dose is high enough and the patients are not given N-acetyl cysteine. Berberine (BBR) has a variety of biological proprieties including anti-inflammatory and antioxidant activities.
Aim:
Assessment of the potential effect of BBR and selenium when used alone or together on the paracetamol–induced acute hepatic toxicity in rats.
Methods:
This research involved 40 clinically healthy mature adult male albino rats, their weights ranged from 150-200 g and housed in standard conditions. Our study involved evaluating the potential effect of BBR and selenium when used alone or together on the paracetamol–induced acute hepatic toxicity via estimation of the liver function tests, determination of the antioxidant enzyme activities, lipid peroxidation markers, immune-modulatory effects, liver histopathological and immunohistochemical studies.
Results:
Co-treatment of BBR (150 mg/kg BW) with selenium (5 mg/kg BW) showed significant improvement in the liver function parameters, the antioxidant enzyme activities, reduction in the nitric oxide, lysozyme, malondialdehyde, TNF-α, and TGF-β1 levels, and marked elevation in the IgM levels.
Conclusion:
Altogether, BBR, Selenium or both augment antioxidant activity and alleviate the paracetamol-induced hepatic toxicity.

Key words: Protective, Berberine, Selenium, Paracetamol, Induced hepatic toxicity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.